The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surufatinib combined with gemcitabine and cisplatin and immune checkpoint inhibitor (ICI) for unresectable locally advanced or metastatic intrahepatic cholangiocarcinoma.
 
Zhong Jing tao
No Relationships to Disclose
 
Shi Xuetao
No Relationships to Disclose
 
Jiang Yubo
No Relationships to Disclose
 
Tian He
No Relationships to Disclose
 
Geng Xiaodan
No Relationships to Disclose
 
Li Lei
No Relationships to Disclose
 
Cui Kai
No Relationships to Disclose
 
Li Zhongchao
No Relationships to Disclose
 
Sun Pengfei
No Relationships to Disclose
 
Zhang Chengsheng
No Relationships to Disclose
 
Zhang Bo
No Relationships to Disclose
 
Zhao Lei
No Relationships to Disclose